Bing

Hologic Inc:Expects Q4 2015 revenue of $685 to $695 million.Expects Q4 2015 Non-GAAP EPS of $0.41 to $0.42.Raises FY 2015 revenue and non-GAAP EPS guidance.Expects FY 2015 revenues of $2.687 to $2.697 bln (previous guidance range was $2.
Reuters · 7/29/2015
© 2015 American City Business Journals. All rights reserved. Use of this Site constitutes acceptance of our User Agreement (updated 12/23/13) and Privacy Policy (updated 12/23/13). The material on this site may not be reproduced, distributed, transmitted ...
The Business Journal · 8/24/2015
When the stock sold off after that skyrocket rally, we told you not to worry. In fact, we recommended you turn that weakness into an opportunity – and accumulate more shares. The corporate insiders seem to share our confident outlook.
Money Morning · 8/7/2015
Value investors were saddened last week by news of the passing of Irving Kahn at the ripe old age of 109. Kahn went to work on Wall Street just before the crash of 1929 where he made money by shorting stocks as the economy sank into the great depression.
moneysense.ca · 3/5/2015
The following five companies are Icahn’s top portfolio holdings as of the close of the second quarter. Icahn’s largest position is in Icahn Enterprises where he holds a massive 105,842,442 shares of the stock. His position takes up 27.4% of his total ...
Guru Focus · 8/17/2014
Monkeying the moves of other investors is rarely a good way to make money — unless you’re aping activists like Carl Icahn. It’s no fluke ... who take 5% or greater positions in a company’s stock. It’s not just a short-term pop, either.
USA TODAY MONEY · ByMatt Krantz · 5/26/2015
RadNet Inc. (RDNT) experienced unusually high volume on May. 13, as the stock lost 4.4% to a closing price of $6.95. The stock saw 671,038 shares trade hands over the course of the day on 4,173 trades. Given that the stock’s average daily volume over …
Equities · 5/13/2015
An updated list of biotech and pharmaceutical companies that have pending FDA drug approval decisions for the ... volume of 21.64 million shares making it the most volume active stock in Biotechnology industry. ARNA has current ratio of 7.44 and its ...
Property Mentor Group · 7/24/2012
The stock market is imploding, Europe is on the brink, and, if the doomsayers are to be believed, we could be headed for a double-dip recession. None of that worries Irving Kahn, perhaps the world’s oldest working investment banker. “There are a lot of ...
Value Walk · ByJacob Wolinsky · 8/23/2011
U.S. News evaluated 35 Mid-Cap Funds ETFs and 14 make our Best Fit list. Our list highlights the best passively managed funds for long-term investors. Rankings are assigned based on comparisons with Best Fit funds in this category.
USNews · 9/1/2013